Home › Funds › PFM Health Sciences, LP › GMAB

PFM Health Sciences, LP position in GMAB

GENMAB A/S · Health Care

PFM Health Sciences, LP reported holding 313,679 shares of GMAB (GENMAB A/S) in its Q3 2026 13F filing — a position valued at US$11.2M, representing 1.14% of its reported portfolio and ranking #31 among its reported holdings. PFM Health Sciences, LP first reported this position in Q3 2026.

Latest position (Q3 2026)313.68K sh
Reported value held$11.19M
Portfolio Weight1.14%
First reportedQ3 2026
Last changeNew
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's GMAB position evolved

PFM Health Sciences, LP first disclosed a stake in GMAB in Q3 2026 at 313,679 shares (US$11.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 313.68K $11.19M New

About GMAB and 13F data

GMAB (GENMAB A/S) is a Health Care company. 37 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$504.3M), Orbis Allan Gray Ltd (US$377.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMAB

All GMAB fund holders →

FAQ

How long has PFM Health Sciences, LP held GMAB?

PFM Health Sciences, LP has disclosed GMAB holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is PFM Health Sciences, LP's current position in GMAB?

As of Q3 2026, PFM Health Sciences, LP holds 313.68K shares of GMAB (GENMAB A/S), valued at $11.19M, representing 1.14% of its reported portfolio and ranking #31.

Has PFM Health Sciences, LP been buying or selling GMAB?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP newly opened its position in GMAB.

Which other funds hold GMAB?

Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.